2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow Malignant Neoplasms of Brain: new trials by email Literature Review of Malignant Neoplasms of Brain trials Research Report on Malignant Neoplasms of Brain
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chemotherapy, Radiation Therapy, and Vaccine Therapy With Basiliximab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery PEP-3-KLH conjugate vaccine, daclizumab, temozolomide - Malignant Neoplasms of Brain | Phase 1 | Completed | John Sampson | 16 | 2007-03-01 | 2016-01-21 |
| Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme tetanus toxoid, therapeutic autologous dendritic cells, therapeutic autologous lymphocytes - Malignant Neoplasms of Brain | Phase 1 | Completed | Gary Archer Ph.D. | 42 | 2006-02-06 | 2023-03-13 |
Glioblastoma (2) · Gliosarcoma (2) · Glioma (1)
Astrocytoma (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Nerve Tissue (2) · Neoplasms, Neuroepithelial (2) · Neuroectodermal Tumors (2) · Glioma (1)
Daclizumab (1) · Temozolomide (1) · Tetanus Toxoid (1) · rindopepimut (1)
Gary Archer Ph.D. (1) · John Sampson (1)
United States (2)
Duane Mitchell, MD, PhD (1) · Katherine Peters, MD, PhD (1)
PMID 22383993, PMID 25762141, PMID 28411277
R21CA132891 (1)